Question special
Lead Moderator

The authors note that hospitalizations for heart failure were not significantly reduced among either patients with type 1 diabetes or their matched controls. However, they were reduced in patients with Type 2 diabetes. The authors write, "These observations suggest that other processes, less well appreciated and therefore less well treated, contributing to heart failure risk are not affected by contemporary clinical care for patients with type 1 diabetes." What might these processes be? What is it about the pathophysiology of Type 1 diabetes and our current treatment strategies that do not mitigate heart failure risk?